perjeta
roche products pty ltd - pertuzumab -
empliciti 300 mg lyphoilisate for solution for infusion powder for concentrate for solution for infusion
bristol-myers squibb, united states - elotuzumab - powder for concentrate for solution for infusion - 300 mg
empliciti 400 mg lyphoilisate for solution for infusion powder for concentrate for solution for infusion
bristol-myers squibb, united states - elotuzumab - powder for concentrate for solution for infusion - 400 mg
besponsa 0.9 mg vial powder for concentrate for solution for infusion
pfizer inc, united states - inotuzumab ozogamicin - powder for concentrate for solution for infusion - 0.9 mg
besponsa™ 0.9 mg/vial
inotuzumab ozogamicin -
besponsa lyophilizate for concentrate for solution for infusion
pharmacia and upjohn company - inotuzumab ozogamicin - lyophilizate for concentrate for solution for infusion - 1mg
empliciti for i.v. infusion 300mg (エムプリシティ点滴静注用300mg)
bristol-myers squibb - elotuzumab - injection
empliciti for i.v. infusion 400mg (エムプリシティ点滴静注用400mg)
bristol-myers squibb - elotuzumab - injection
mylotarg injection 5mg (マイロターグ点滴静注用5mg)
pfizer pharmaceuticals inc. - gemtuzumab ozogamicin (genetical recombination) - injection
perjeta concentrate solution for infusion 420 mg
al jishi pharmacy - pertuzumab - concentrate solution for infusion - 420